Skip to content

Clinical trials

Completed Adenocarcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Spain Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20083
20093
20101
20121
20131
20143
20164
20171
20181
20191
20201
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Eli Lilly and Company2
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1
Cantargia AB1
Celgene1
Clinica Universidad de Navarra, Universidad de Navarra1
Genzyme, a Sanofi Company1
Grupo Espanol Multidisciplinario del Cancer Digestivo1
Grupo Espanol de Tumores Neuroendocrinos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma27
Carcinoma, Non-Small-Cell Lung8
Carcinoma7
Neoplasm Metastasis6
Neoplasms6
Stomach Neoplasms6
Lung Neoplasms5
Colorectal Neoplasms4
Digestive System Diseases4
Digestive System Neoplasms4

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.